Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
14.36
-0.17 (-1.17%)
At close: May 12, 2025, 4:00 PM
14.36
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
Pediatrix Medical Group Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Pediatrix Medical Group stock have an average target of 16.67, with a low estimate of 15 and a high estimate of 20. The average target predicts an increase of 16.09% from the current stock price of 14.36.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pediatrix Medical Group stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 5 | 5 | 5 | 5 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $19 → $16 | Hold | Maintains | $19 → $16 | +11.42% | May 12, 2025 |
| Macquarie | Macquarie | Buy Maintains $19 → $20 | Buy | Maintains | $19 → $20 | +39.28% | May 8, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $18 → $16 | Hold | Maintains | $18 → $16 | +11.42% | Apr 11, 2025 |
| UBS | UBS | Hold Maintains $17 → $19 | Hold | Maintains | $17 → $19 | +28.83% | Feb 21, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $15 → $18 | Hold | Maintains | $15 → $18 | +25.35% | Feb 21, 2025 |
Financial Forecast
Revenue This Year
1.93B
from 2.01B
Decreased by -4.37%
Revenue Next Year
1.98B
from 1.93B
Increased by 2.65%
EPS This Year
1.59
from -1.19
EPS Next Year
1.67
from 1.59
Increased by 5.39%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.1B | 2.1B | 2.2B | ||
| Avg | 1.9B | 2.0B | 2.1B | ||
| Low | 1.8B | 1.8B | 1.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.2% | 10.4% | 13.6% | ||
| Avg | -4.4% | 2.6% | 5.0% | ||
| Low | -12.3% | -5.7% | -5.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.70 | 1.89 | 2.10 | ||
| Avg | 1.59 | 1.67 | 1.69 | ||
| Low | 1.38 | 1.40 | 1.36 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 18.7% | 25.4% | ||
| Avg | - | 5.4% | 1.2% | ||
| Low | - | -11.8% | -18.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.